Acoustic pressure shock waves are applied to a drug delivery structure implanted in tissue of a human or animal body and including one or more pouches that contain at least one drug in fluid form that is releasable from the drug delivery structure when targeted by the acoustic pressure shock waves.

Apparatus and methods for treating dry eye include an energy source configured to apply energy to an obstruction located in a meibomian gland of a patient's eyelid. The apparatus also comprises an insulator configured to be positioned between a rear portion of the patient's eyelid and a surface of the patient's eyeball. An inner surface of the insulator has a curvature greater than that of the patient's eyeball such that an air pocket is formed between the inner surface of the insulator and the patient's eyeball, wherein the air pocket provides additional insulation to reduce or eliminate an amount of heat due to the applied energy from the energy source from being conducted to the surface of the patient's eyeball, such that the applied energy does not cause the temperature to reach a temperature sufficient to cause damage to a corneal or scleral portion of the patient's eyeball.

An extracorporeal pressure shock wave device includes a hinge providing a pivotable axis about which a shock wave applicator rotates to provide for adjusting the depth within a targeted body that a shock wave focal volume is produced from the applicator.

A system of devices for treating an artery includes an arterial access sheath adapted to introduce an interventional catheter into an artery and an elongated dilator positionable within the internal lumen of the sheath body. The system also includes a catheter formed of an elongated catheter body sized and shaped to be introduced via a carotid artery access site into a common carotid artery through the internal lumen of the arterial access sheath. The catheter has an overall length and a distal most section length such that the distal most section can be positioned in an intracranial artery and at least a portion of the proximal most section is positioned in the common carotid artery during use.

Systems, devices and methods for removing a blood clot (10) from a blood vessel (12). Various uses of suction pressure and positive pressure, proximal and/or distal to the blood clot (10) assist with clot dislodgement and removal. The pressure(s) may be constant and/or cycled/pulsed to assist with clot dislodgement and/or removal. Various further devices assist with separating the clot (10) from the vessel (12).

Retrieval of material from vessel lumens can be improved by electrically enhancing attachment of the material to the thrombectomy system. The system can include a catheter having a distal portion configured to be positioned adjacent to a thrombus in a blood vessel, an electrode disposed at the distal portion of the catheter, and an interventional element configured to be delivered through a lumen of the catheter. The electrode and the interventional element are each configured to be electrically coupled to an extracorporeal power supply.

A method of removing a kidney stone from the kidney and ureter of a human includes the steps of introducing a laminar flowing fluid via a ureteroscope into the ureter or kidney and proximal the kidney stone and flowing inward toward the kidney and then switching the laminar flow to a turbulent flow which causes a reverse flow that moves the kidney stone in a direction away from the kidney and down the ureter toward the bladder where the stone may be removed using a wire basket. In one step the kidney stone may first be fragmented into smaller kidney stones or fragments prior to switching to the turbulent flow.

A vascular device for treating a tract of a blood vessel has an intraluminal element having at least one dispensing opening for dispensing a pharmacological agent in the tract of the blood vessel, and an abrasion element coming into contact with an inner wall of the blood vessel to remove material from the inner wall. The abrasion element has a contact portion for removing the material and a collection portion for collecting the removed material. and is configured to expand between a rest configuration and a contact configuration. The abrasion element has a first surface facing the intraluminal element and configured to face a fluid inside the blood vessel. The first surface in the contact configuration forms a concave portion adapted to face the fluid inside the blood vessel. The collection portion includes the concave portion to collect the material removed from the inner wall treated with the pharmacological agent.

Disclosed herein are systems, devices, and methods for the removal of objects from the body. The device may be a urethral catheter configured to aspirate kidney stones from the urinary tract through one or more aspiration ports at the distal face or along a lateral side of the catheter. The catheter may include one or more irrigation ports at the distal face or along the lateral side of the catheter for dislodging kidney stones. The device may be steerable. The spatial arrangement of the one or more irrigation ports with respect to the one or more aspiration ports may vary. The device may include an irrigation tube and/or a shield member configured to spatially confine the kidney stones adjacent the catheter. Various temporal patterns of aspiration and irrigation are disclosed for optimizing removal of kidney stones.

A medical device is disclosed for cutting substances inside a body lumen, the medical device including a rotatable tubular drive shaft; a treatment member arranged on a distal side of the drive shaft; and a device handle configured to retract the drive shaft, the device handle comprising: a fixed guide cover disposed to cover the drive shaft and an outer sheath disposed to cover the guide cover; and an annular gap between the outer sheath and the guide cover on a proximal side of a fluid connection configured to supply a physiological salt solution into the outer sheath.